Listen "Vir Biotechnology: Tackling Infectious Disease"
Episode Synopsis
Ηear from Dr. George Scangos, CEO of Vir Biotechnology, about how Vir combines immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, one of the leading causes of death worldwide. Vir is tackling the world’s largest and most serious infectious diseases, infections that are evasive, challenging, or insufficiently addressed by current approaches, including hepatitis B, influenza A, SARS-CoV-2, HIV, and tuberculosis.
Speaker:
Dr. George Scangos, CEO, Vir Biotechnology & Former CEO, Biogen
Moderator:
Anna Protopapas, CEO Mersana Therapeutics
Speaker:
Dr. George Scangos, CEO, Vir Biotechnology & Former CEO, Biogen
Moderator:
Anna Protopapas, CEO Mersana Therapeutics
More episodes of the podcast Hellenic Innovation Network - Podcasts
Greek Visionaries in Life Science
24/05/2023
The State of Greek Venture Capital
07/02/2022
Interview with Dr. Christos Bartsocas
28/01/2022
Why Set up Shop in Greece?
14/06/2021
Digital Transformation
11/05/2021
From Greek Start-Up to Global Scale-Up
12/04/2021
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.